Find A Doctor

Dr. Bhagwant Rai Mittal

Professor & Head

Book an Appointmentarrow
chairperson

Dr. B.R. Mittal is a renowned Nuclear Medicine Physician with more than 38 years’ experience in the field. He is the first person to earn the MD degree in Nuclear Medicine in India. Dr. Mittal is instrumental in establishing the state of the art nuclear medicine department at PGIMER, Chandigarh which is one of the best not only in the country but across the globe. He is credited with starting MD and MSc in nuclear medicine at PGIMER, Chandigarh. Dr. Mittal has organized many conferences/CMEs. He also possesses rich administrative experience.

He is former
Director – IMS, BHU, Varanasi
Sub-Dean Academics, PGIMER, Chandigarh
Sub-Dean Research, PGIMER, Chandigarh
Prof. & Head, Dept. of Nuclear Medicine, PGIMER, Chandigarh

Interest: General Nuclear Medicine, Therapeutic Nuclear Medicine

  • Homi Bhabha Oration Award
  • Dr. RD Lele Oration Award
  • Hal Oscar Anger Oration Award
  • Dean, Indian College of Nuclear Medicine (2017-2019 & 2023-2025)
  • Editor-in-Chief, Indian Journal of Nuclear Medicine (2013-2020)
  • President, Society of Nuclear Medicine, India (2009-2011)
  • Council Member, National Academy of Medical Sciences
  • Fellow, International Union against Cancer (F-UICC)
  • Fellow, National Academy of Medical Sciences (FAMS)
  • Fellow, Indian College of Nuclear Medicine (FICNM)
  • Life Member, National Academy of Medical Sciences (MNAMS)
  • Founder Member, Indian College of Nuclear Medicine (MICNM)
  • Life Member, Indian Medical Association (IMA)
  • Life Member, Indian Nuclear Society (INA)
  • Life Member, Association of Nuclear Medicine Physicians of India (ANMPI)
  • Life Member, Society of Nuclear Medicine India (SNMI)
  • Life Member, Northern Chapter, SNM India (SNM-NC)
  • Life Member, Nuclear Cardiology Society of India (NCSI)
  • Life Member, Indian Thyroid Society (ITS)
  • Life Member, Indian Society of Bone and Mineral Research (ISBMR)
  • Member, Society of Nuclear Medicine & Molecular Imaging, USA (SNMMI)
  • Member, American Society of Nuclear Cardiology (ASNC)
  • Member, European Society of Nuclear Medicine (EANM)
  • Member, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
  • Dean, Indian College of Nuclear Medicine (2017–2019 and 2023–2025)
  • Ex Editor-in-Chief, Indian Journal of Nuclear Medicine
  • Member, Editorial Board of Indian Journal of Nuclear Medicine
  • Member, Editorial Board of Hellenic Journal of Nuclear Medicine
  • Member, Editorial Board, NCSI Newsletter
  • Member, Executive Committee of SNM India (1991–1993)
  • Hon. Secretary (II), Society of Nuclear Medicine India (1997–1999)
  • Member, Executive Committee of NCSI (2005–2007)
  • President-Elect, Society of Nuclear Medicine India (2007–2009)
  • President, Society of Nuclear Medicine India (2009–2011)
  • President, Nuclear Cardiological Society of India (2015–2017)

700, in peer reviewed international and national journals of repute.

Research Guidance: PhD (13), MD (40), MSc (25); Co-guide- MD/MS/DM/Mch (91)

  • Kumar R, Krishnaraju VS, Mittal BR, Shankar K, Singh H, Ramachandran A, Bhattacharya A, Prakash G, Bal A, Malhotra P. Pathologic Validation of Deauville Score-Based Disease on F-18 FDG PET/CT after First-Line Treatment in Patients with Lymphoma. Nucl Med Mol Imaging. 2024 Jun 15;58(6):332-340. doi: 10.1007/s13139-024-00868-z. PMCID: PMC11415326
  • Aggarwal P, Satapathy S, Sood A, Goyal S, Prakash G, Mittal BR. IUC24402-77 Preliminary results of 177Lu-PSMA-617 priming with enzalutamide in metastatic castration-resistant prostate cancer: a single-arm phase 2 trial (Lu-PRIME). Oncologist. 2025 Aug 29;30(Suppl 1):oyaf248.036. doi: 10.1093/oncolo/oyaf248.036. PMCID: PMC12396356
  • Pandey S, Walia R, Kaur G, Pandav K, Rather I, Rana N, Sahoo S, Mittal BR, Shukla J. Using the PET/CT radiotracer [68Ga]Ga-DOTA-mDesmo to target V1b receptors and localize corticotropinoma in Cushing's disease. Commun Med (Lond). 2025 Aug 22;5(1):367. doi: 10.1038/s43856-025-01033-z. PMCID: PMC12373759
  • Kumar SA, Singh H, Kaman L, Nada R, Mittal BR. Annotating the Role of 18F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies-Is It Really an Advantageous Tool? Nucl Med Mol Imaging. 2024 Feb 14;58(3):140-146. doi: 10.1007/s13139-024-00846-5. PMCID: PMC11018563
  • Satapathy S, Mittal BR, Sood A, Das CK, Mavuduru RS, Goyal S, Shukla J, Singh SK. [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial. J Nucl Med. 2023 Nov;64(11):1726-1729. doi: 10.2967/jnumed.123.266141. PMID: 37709534
  • Aggarwal P, Gunasekaran V, Sood A, Gupta K, Das CK, Mittal BR. Sunitinib in Tandem With 177Lu-DOTATATE Therapy in Advanced Pancreatic Neuroendocrine Tumor: A New Treatment Approach. Clin Nucl Med. 2024 Feb 1;49(2):e85-e86. doi: 10.1097/RLU.0000000000005018. PMID: 38109041
  • Satapathy S, Das CK, Aggarwal P, Sood A, Parihar AS, Singh SK, Mittal BR. Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience. Prostate. 2023 Feb;83(2):169-178. doi: 10.1002/pros.24450. PMID: 36259290
  • Kaur K, Nagi S, Satapathy S, Aggarwal P, Sood A, Mittal BR. Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177Lu-PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study. Nucl Med Commun. 2024 Feb 1;45(2):115-120. doi: 10.1097/MNM.0000000000001792. PMID: 37982573
  • Chopra S, Singh SS, Sood A, Parmar M, Parihar AS, Vadi SK, Mittal BR. Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction. J Nucl Cardiol. 2023 Oct;30(5):1782-1793. doi: 10.1007/s12350-023-03210-w. PMID: 38245121
  • Vatsa R, Kaur D, Shekhar SS, Chhabra A, Chakraborty S, Dash A, Shukla J, Mittal BR. Comparison of 99mTc-methylenediphosphonate and 68Ga-BPAMD PET/computed tomography imaging in bone metastasis. Nucl Med Commun. 2023;44(6):463–470. doi: 10.1097/MNM.0000000000001685
  • Watts A, Singh B, Singh H, Bal A, Kaur H, Dhanota N, Arora SK, Mittal BR, Behera D. [68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density by immunochemistry techniques. Eur J Nucl Med Mol Imaging. 2023;50(4):1216–1227. PMID: 36482077
  • Satapathy S, Kumar R, Kavanal AJ, Krishnaraju VS, Ramachandran A, Deo P, Dhir V, Mittal BR. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of 18F-FDG PET/CT to assess myocardial involvement. J Nucl Cardiol. 2022 Dec;29(6):3546-3547. doi: 10.1007/s12350-021-02540-x. PMID: 33624189
  • Kumar R, Singh SK, Mittal BR, Vadi SK, Kakkar N, Singh H, Krishnaraju VS, Kumar S, Bhattacharya A. Safety and Diagnostic Yield of 68Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy. Radiology. 2022 May;303(2):392-398. doi: 10.1148/radiol.204066. PMID: 35191735
  • Satapathy S, Mittal BR, Sood A, Das CK, Mavuduru RS, Goyal S, Shukla J, Singh SK. 177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1754-1764. doi: 10.1007/s00259-021-05618-3. PMID: 34842950
  • Ashwathanarayana AG, Singhal M, Satapathy S, Sood A, Mittal BR, Kumar RM, Parmar M, Krishnappa D, Rana N. 18F-NaF PET uptake characteristics of coronary artery culprit lesions in a cohort of patients of acute coronary syndrome with ST-elevation myocardial infarction and chronic stable angina: A hybrid fluoride PET/CTCA study. J Nucl Cardiol. 2022 Apr;29(2):558-568. doi: 10.1007/s12350-020-02284-0. PMID: 32720061
  • Palayullakandi A, Trehan A, Jain R, Kumar R, Mittal BR, Kapoor R, Srinivasan R, Kakkar N, Bansal D. Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting. Pediatr Hematol Oncol. 2022 Oct;39(7):587-599. doi: 10.1080/08880018.2022.2044418. PMID: 35271413
  • Kudo T, Lahey R, Hirschfeld CB, Williams MC, Lu B, Alasnag M, Bhatia M, Henry Bom HS, Dautov T, Fazel R, Karthikeyan G, Keng FYJ, Rubinshtein R, Better N, Cerci RJ, Dorbala S, Raggi P, Shaw LJ, Villines TC, Vitola JV, Choi AD, Malkovskiy E, Goebel B, Cohen YA, Randazzo M, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ; INCAPS COVID Investigators Group. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study. JACC Asia. 2021 Sep 21;1(2):187-199. doi: 10.1016/j.jacasi.2021.06.002. PMID: 36338167
  • Vadi SK, Sood A, Khadwal A, Parmar M, Bhatia A, Kashyap S, Bahl A, Mittal BR. Exploring the potential utilities of 99mTc-labeled RBC-equilibrium radionuclide angiocardiography in transfusion-dependent β-thalassemia major patients. Nucl Med Commun. 2021 Dec 1;42(12):1313-1321. doi: 10.1097/MNM.0000000000001467. PMID: 34392295
  • Satapathy S, Mittal BR, Sood A, Sood A, Kapoor R, Gupta R, Khosla D. 177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors: A Single-Institution Experience. JCO Glob Oncol. 2021 Jul;7:1167-1175. doi: 10.1200/GO.21.00103
  • Satapathy S, Bhattacharya A, Sood A, Kapoor R, Gupta R, Sood A, Sharma P, Khosla D, Mittal BR. Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors. Cancer Biother Radiopharm. 2022 Feb;37(1):23-29. doi: 10.1089/cbr.2021.0053. PMID: 34147434
  • Satapathy S, Das N, Sood A, Goyal S, Madan R, Mittal BR. Short-course 177Lu-PSMA-617 Radioligand Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer: Time to Take the Leap? Eur Urol. 2021 Sep;80(3):390-392. doi: 10.1016/j.eururo.2021.06.012
  • Hirschfeld CB, Shaw LJ, Williams MC, Lahey R, Villines TC, Dorbala S, Choi AD, Shah NR, Bluemke DA, Berman DS, Blankstein R, Ferencik M, Narula J, Winchester D, Malkovskiy E, Goebel B, Randazzo MJ, Lopez-Mattei J, Parwani P, Vitola JV, Cerci RJ, Better N, Raggi P, Lu B, Sergienko V, Sinitsyn V, Kudo T, Nørgaard BL, Maurovich-Horvat P, Cohen YA, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ; INCAPS-COVID Investigators Group. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study. JACC Cardiovasc Imaging. 2021 Sep;14(9):1787-1799. doi: 10.1016/j.jcmg.2021.03.007. PMID: 34147434
  • Krishnaraju VS, Saikia UN, Bhadada SK, Mittal BR, Sood A, Singh P, Dahiya D, Kumari P. Cystic Parathyroid Adenomas: An Enigmatic Entity and Role of Tc-99m Sestamibi Scintigraphy. Endocr Pract. 2021 Jun;27(6):614-620.
  • Krishnaraju VS, Kumar R, Sood A, Shukla J, Subramanian K, Kakkar N, Panda N, Mittal BR. Angiogenesis-Targeted 68Ga-DOTA-RGD2 PET/CT Imaging: A Potential Theranostic Application in the Case of Chondrosarcoma. Nucl Med Mol Imaging. 2021 Jun;55(3):141-145.
  • Krishnaraju VS, Singh H, Kumar R, Sharma S, Mittal BR, Bhattacharya A. Infection imaging using [18F]FDG-labelled white blood cell positron emission tomography-computed tomography. Br J Radiol. 2021 Jun 1;94(1122):20201204. doi: 10.1259/bjr.20201204.
  • Bollampally N, Shukla J, Mittal BR, Sood A, Mohanty M, Kapoor R, Vatsa R, Satapathy S, Chakravarty R, Chakraborty S, Dash AAK. Efficacy and safety of 177Lu-DOTMP in palliative treatment of symptomatic skeletal metastases: a prospective study. Nucl Med Commun. 2021 Sep 1;42(9):964-971. doi: 10.1097/MNM.0000000000001425. PMID: 33852531
  • Kavanal AJ, Bhattacharya A, Sharma A, Shukla J, Chattopadhyay A, M B A, Sharma V, Vatsa R, Rana N, Kaur G, Mittal BR. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis. Clin Nucl Med. 2021 Jul 1;46(7):556-561. doi: 10.1097/RLU.0000000000003586. PMID: 33782288
  • Krishnaraju VS, Kumar R, Patro SK, Bhattacharya A, Singh H, Mittal BR. Incremental Role of 18F-FDG-Labeled Autologous Leukocyte PET/CT in Suspected Postoperative Recurrence of Skull Base Osteomyelitis. Clin Nucl Med. 2021 Jun 1;46(6):507-509.
  • Satapathy S, Sood A, Das CK, Mittal BR. Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer—a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):880-890. doi: 10.1038/s41391-021-00349-w.
  • Jha A, Taieb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru A, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. High-specific-activity 131I-MIBG vs 177Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2021 Jun 1;27(11):2989-2995. doi: 10.1158/1078-0432.CCR-20-3703. PMID: 33685867
  • Kumar R, Vankadari K, Mittal BR, Bansal D, Trehan A, Sahu JK, Sankhyan N. Diagnostic values of 68Ga-labelled DOTANOC PET/CT imaging in pediatric patients presenting with paraneoplastic opsoclonus myoclonus ataxia syndrome. Eur Radiol. 2021 Jul;31(7):4587-4594. doi: 10.1007/s00330-020-07587-x. PMID: 33409780
  • Krishnaraju VS, Kumar R, Mittal BR, Sharma V, Singh H, Nada R, Bal A, Rohilla M, Singh H, Rana SS. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue. Eur Radiol. 2021 Apr;31(4):2199-2208. doi: 10.1007/s00330-020-07318-2. PMID: 33001304
  • Hirschfeld CB, Mercuri M, Pascual TNB, Karthikeyan G, Vitola JV, Mahmarian JJ, Better N, Bouyoucef SE, Hee-Seung Bom H, Lele V, Magboo VPC, Alexánderson E, Allam AH, Al-Mallah MH, Dorbala S, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Shaw LJ, Underwood SR, Rehani MM, Paez D, Dondi M, Einstein AJ; INCAPS Investigators Group. Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging Protocols. JACC Cardiovasc Imaging. 2021 Jan 4:S1936-878X(20)31016-0. doi: 10.1016/j.jcmg.2020.11.011.
  • Satapathy S, Singh H, Kumar R, Mittal BR. Diagnostic accuracy of 68Ga-PSMA PET/CT for initial detection in patients with suspected prostate cancer: A systematic review and meta-analysis. AJR Am J Roentgenol. 2021 Mar;216(3):599-607.
  • Parihar AS, Dabas G, De D, Sood A, Jois AGA, Radotra BD, Mittal BR. Necrolytic Acral Erythema in Association with Hypothyroidism. JAMA Dermatol. 2020 Nov 1;156(11):1268-1270.
  • Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Saranovic DS, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB. Sequential 18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) Scan Findings in Patients with Extrapulmonary Tuberculosis During the Course of Treatment—A Prospective Observational Study. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3118-3129.
  • Satapathy S, Mittal BR, Sood A, Verma R, Panda N. Efficacy and safety of concomitant 177Lu-DOTATATE and low-dose capecitabine in advanced medullary thyroid carcinoma: a single-centre experience. Nucl Med Commun. 2020 Jul;41(7):629-635.
  • Jain A, Goyal MK, Mittal BR, Sood A, Singh H, Vyas S, Sharma K, Sharma N, Kumar R, Rebello A, Narang D, Tandyala N, Prabhat N, Dutta S, Modi M, Lal V. 18FDG-PET Is Sensitive Tool for Detection of Extracranial Tuberculous Foci in Central Nervous System Tuberculosis—Preliminary Observations from a Tertiary Care Center in Northern India. J Neurol Sci. 2020 Feb 15;409:116585. doi: 10.1016/j.jns.2019.116585.
  • Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Sobic Saranovic D, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB; International Atomic Energy Agency Extra-pulmonary TB Consortium. PET/CT features of Extrapulmonary Tuberculosis at first clinical presentation—a cross-sectional observational 18F-FDG imaging study across six countries. Eur Respir J. 2020 Feb 27;55(2):1901959.
  • Kumar R, Mittal BR, Bhattacharya A, Vadi SK, Singh H, Bal A, Shukla J, Singh H, Sharma V, Sood A, Singh SK. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm. Diagn Interv Imaging. 2020 Mar;101(3):157-167.
  • Satapathy S, Mittal BR. 177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Nucl Med Commun. 2019 Dec;40(12):1195-1203.
  • Satapathy S, Mittal BR, Bhansali A. Peptide Receptor Radionuclide Therapy in the Management of Advanced Pheochromocytoma and Paraganglioma: A Systematic Review and Meta-analysis. Clin Endocrinol (Oxf). 2019 Dec;91(6):718-727.
  • Malik D, Mittal B, Sood A, Parmar M, Kaur G, Bahl A. Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI. J Nucl Cardiol. 2019 Oct;26(5):1650-1658.
  • Sharma A, Kumar R, Mb A, Naidu G, Sharma V, Sood A, Dhir V, Verma R, Singh H, Bhattacharya A, Jain S, Mittal BR. Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis. Rheumatology (Oxford). 2020 Jan 1;59(1):99-106.
  • Rayamajhi SJ, Yeh R, Wong T, Dumeer S, Mittal BR, Remotti F, Chikeka I, Reddy AK. Tumor-induced osteomalacia - Current imaging modalities and a systematic approach for tumor localization. Clin Imaging. 2019 Apr 17;56:114-123.
  • Mittal BR. 50 Years of Society of Nuclear Medicine, India. Indian J Nucl Med. 2018 Nov;33(Suppl 1):S11.
  • Kumar R, Mittal BR, Bhattacharya A, Singh H, Bal A, Prakash G, Singh N. 18F-FDG PET/CT-Guided Real-Time Automated Robotic Arm-Assisted Needle Navigation for Percutaneous Biopsy of Hypermetabolic Bone Lesions: Diagnostic Performance and Clinical Impact. AJR Am J Roentgenol. 2019 Jan;212(1):W10-W18.
  • Parihar AS, Sood A, Kumar R, Bhusari P, Shukla J, Mittal BR. Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1836-1837.
  • Malik D, Kumar R, Mittal BR, Singh H, Bhattacharya A, Sood A, Sharma V, Singh H. 68Ga-labelled PSMA (prostate specific membrane antigen) expression in signet-ring cell gastric carcinoma. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1276-1277.
  • Mittal BR, Sood A, Shukla J, Vatsa R, Bhusari P, Shree R, Mehta S, Goyal M, Modi M. 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes. Nucl Med Commun. 2018 Apr;39(4):312-318.
  • Vadi SK, Mittal BR, Gorla AKR, Sood A, Basher RK, Sood A, Kakkar N, Sen RK. 18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients with Suspected Recurrence of Chondrosarcoma. Clin Nucl Med. 2018 Feb;43(2):87-93.
  • Radhakrishnan RK, Mittal BR, Basher RK, Prakash G, Malhotra P, Kalra N, Das A. Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm. Nucl Med Commun. 2018 Jan;39(1):74-82.
  • Radhakrishnan RK, Mittal BR, Gorla AKR, Basher RK, Sood A, Bal A, Kalra N, Khandelwal N, Singh N, Behera D. Real time intra-procedural 18F-FDG PET/CT guided biopsy using automated robotic biopsy arm (ARA) in the evaluation of thoracic lesions with prior inconclusive biopsy results. Br J Radiol. 2017 Dec;90(1080):20170258.
  • Mittal BR, Singh S. Hybrid PET/MR imaging for evaluation of recurrence in gliomas: Standard of care or luxury? Neurol India. 2017 Mar-Apr;65(2):302-304.
  • Sood V, Mittal BR, Bhansali A, Singh B, Khandelwal N, Marwaha N, Jain A. Biodistribution of 18F-FDG-Labeled Autologous Bone Marrow-Derived Stem Cells in Patients With Type 2 Diabetes Mellitus: Exploring Targeted and Intravenous Routes of Delivery. Clin Nucl Med. 2015 Sep;40(9):697-700.
  • Agrawal K, Esmail AA, Gnanasegaran G, Navalkissoor S, Mittal BR, Fogelman I. Pitfalls and Limitations of Radionuclide Imaging in Endocrinology. Semin Nucl Med. 2015 Sep;45(5):440-457.
  • Santhosh S, Mittal BR, Rana SS, Srinivasan R, Bhattacharya A, Das A, Bhasin D. Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlation. Abdom Imaging. 2015 Jun;40(5):1285-1315.
  • Santhosh S, Mittal BR, Kang M, Kapoor R, Gupta R, Rana S, Bhattacharya A, Bhasin D. Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance. Abdom Imaging. 2015 Jun;40(5):1131-1137.
  • Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropics. J Nucl Cardiol. 2014;21(5):993–1000.
  • Kashyap R, Mittal BR, Khaliq A, Manrai M, Appasani S, Bhattacharya A, Khandelwal N, Kochhar R. Role of N-13 ammonia PET/CT in diagnosing pancreatic necrosis in patients with acute pancreatitis as compared to contrast enhanced CT - Results of a pilot study. Pancreatology. 2014 May-Jun;14(3):154-158.
  • Mittal BR. Striving toward excellence. Indian J Nucl Med. 2014 Jan;29(1):1.
  • Manohar K, Mittal BR, Jain S, Sharma A, Kalra N, Bhattacharya A, Varma S. F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin. Jpn J Radiol. 2013;31(5):320–327.
  • Mittal BR, Singh RK, Kumari S, Manohar K, Bhattacharya A, Singh G. Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Indian J Nucl Med. 2012 Oct;27(4):221-225.
  • Mittal BR, Bhoil A, Kashyap R, Bhattacharya A, Dutta U, Kochhar R. 99mTc-Pertechnetate Scintigraphy and Endoscopy in Assessment of Caustic-Induced Gastric Mucosal Injury. Clin Nucl Med. 2013 Mar;38(3):e146-147.
  • Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R. Role of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Characterization of Pancreatic Masses: Experience from Tropics. J Gastroenterol Hepatol. 2013 Feb;28(2):255-261.
  • Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Ann Nucl Med. 2013;27:146–151.
  • Manohar K, Mittal BR, Bhattacharya A, Malhotra P, Varma S. Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma. Nucl Med Commun. 2012 Sep;33(9):974-981.
  • Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Nucl Med Commun. 2012 Jun;33(6):591-596.
  • Bhadada SK, Sridhar S, Ahluwalia J, Bhansali A, Malhotra P, Behera A, Mittal BR. Anemia and Thrombocytopenia Improves after Curative Parathyroidectomy in a Patient of Primary Hyperparathyroidism (PHPT). J Clin Endocrinol Metab. 2012 May;97(5):1420-1422.
  • Kashyap R, Mittal BR, Manohar K, Harisankar CNB, Bhattacharya A, Singh B, Malhotra P, Varma S. Extranodal manifestations of lymphoma on [18F]FDG-PET/CT: a pictorial essay. Cancer Imaging. 2011;11:166-174.
  • Mittal BR, Santhosh S, Kashyap R, Bhattacharya A, Singh B, Bahl A. Ventricular ejection fraction in patients with dilated cardiomyopathy calculated by gated blood pool SPET processing software: correlation with multigated acquisition and first pass radionuclide ventriculography. Hell J Nucl Med. 2011 Sep;14(3):234-238.
  • Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G. The role of 18F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging. Hell J Nucl Med. 2011;14(2):135-139.
  • Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, Gupta R. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level. Nucl Med Commun. 2011 Sep;32(9):789-793.
  • Mittal BR, Manohar K, Malhotra P, Das R, Kashyap R, Bhattacharya A, Varma N, Varma S. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging? Leuk Lymphoma. 2011 Nov;52(11):2111-2116.
  • Agrawal K, Bhattacharya A, Harisankar CN, Abrar ML, Mittal BR, Tripathy SK, Sen RK. [(18)F]Fluoride and [(18)F]fluorodeoxyglucose PET/CT in myositis ossificans of the forearm. Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1956.
  • Kashyap R, Mittal BR, Bhattacharya A, Manojkumar R, Singh S. Exercise myocardial perfusion imaging to evaluate inducible ischaemia in children with Kawasaki disease. Nucl Med Commun. 2011 Feb;32(2):137-141.
  • Mittal BR, Kochhar R, Shankar R, Bhattacharya A, Solanki K, Nagi B. Delayed gastric emptying in patients with caustic ingestion. Nucl Med Commun. 2008;29(9):782-785.
  • Mittal BR, Sunil HV, Bhattacharya A, Singh B. Hepatobiliary scintigraphy in management of bile leaks in patients with blunt trauma abdomen. ANZ J Surg. 2008;78(7):597-600.
  • Mittal BR, Kashyap R, Bhattacharya A, Singh B, Radotra BD, Rao KLN. Meckel's diverticulum in infants and children; technetium-99m pertechnetate scintigraphy and clinical findings. Hell J Nucl Med. 2008;11(1):26-29.
  • Kochhar R, Mittal BR, Kumar S, Bhattacharya A, Sethy PK, Dutta U. Segmental and total oesophageal transit time in patients with corrosive-induced oesophageal stricture. Nucl Med Commun. 2007;28(12):920-923.
  • Dutta P, Bhansali A, Mittal BR, Singh B, Masoodi SR. Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot. Foot Ankle Int. 2006;27(9):716-722.
  • Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol (Oxf). 2006;65(3):340-345.
  • Mittal BR, Singh S, Bhattacharya A, Prasad V, Singh B. Lung scintigraphy in the diagnosis and follow-up of pulmonary thromboembolism in children with nephrotic syndrome. Clin Imaging. 2005;29(5):313-316.
  • Mittal BR, Sud K, Singh B. Evaluation of early graft dysfunction in living related transplant patients: role of 99mTc-DTPA scintigraphy. Hell J Nucl Med. 2002;3:182-185.
  • Mittal BR, Gupta D, Jindal SK. Radioisotope bone scanning in pulmonary alveolar microlithiasis. Clin Nucl Med. 2000;25(6):474.
  • Mittal BR, Dhiman RK, Maini A, Sewatkar AB, Das BK. Gastric emptying in patients with non-ulcer dyspepsia (dysmotility type). Trop Gastroenterol. 1997;18(2):67-69.
  • Mittal BR, Kumar P, Arora P, Kher V, Singhal MK, Maini A, Das BK. Role of captopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis. 1996;28(2):209-213.
  • Mittal BR, Wanchu A, Das BK, Ghosh PP, Sewatkar AB, Misra RN. Pattern of gastric emptying in patients with systemic sclerosis. Clin Nucl Med. 1996;21(5):379-382.
  • Mittal BR, Maini A, Das BK: Peritoneopleural communication associated with cirrhotic ascites: scintigraphic demonstration. Abdom Imaging. 21(1):69-70. 1996.
  • Mittal BR, Ibrarullah M, Agarwal DK, Maini A, Ali W, Sikora SS, Das BK: Comparative evaluation of scintigraphy and upper gastrointestinal tract endoscopy for detection of duodenogastric reflux. Ann Nucl Med. 8(3):183-6, 1994.
  • Mittal BR, Ibrarullah MD, Sikora SS, Das BK: Internal biliary fistula after cholecystectomy. Clin Nucl Med. 18(12):1095, 1993.
  • Subramanian K, Aggarwal P, Hall LT, Singh H, Takalkar AM, Mittal BR. Molecular Imaging of Hepatobiliary Cancers. In: Hall LT, editor. Molecular Imaging and Therapy [Internet]. Brisbane (AU): Exon Publications; 2023 Nov 8. Chapter 7. PMID: 38190479
  • Krishnaraju VS, Singh H, Hall LT, Takalkar AM, Mittal BR. Molecular Imaging of Breast Cancer. In: Hall LT, editor. Molecular Imaging and Therapy [Internet]. Brisbane (AU): Exon Publications; 2023 Nov 8. Chapter 6. PMID: 38190472
  • Mittal BR, Singh H. Nuclear Medicine. In: Kamath S et al. editors. API Text Book of Medicine (12th ed.). Delhi: Jaypee Brothers Medical Publishers; 2022. p. e1235–1254. ISBN: 978-93-5465-636-1
  • Parihar AS, Mittal BR. Single Photon Emission Imaging in Glomerular and Tubular Renal Diseases. In: Nephro Encyclopedia. In Press. DOI
  • Parihar AS, Mittal BR. Gamma Camera Imaging of Renal Transplant. In: Nephro Encyclopedia. In Press. DOI
  • Kumar R, Sood A, Singh H, Mittal BR. Positron Emission Tomography/Computed Tomography Imaging in Abdominal Tuberculosis. In: Sharma V, editor. Tuberculosis of the Gastrointestinal System. Springer, Singapore; 2022. p. 301–313. DOI
  • Gorla AKR, Agrawal K, Parihar AS, Mittal BR. 18F-methylcholine (FCH) PET/CT Imaging: Physiological Distribution, Pitfalls and Imaging Pearls. In: Agrawal K, Skillen A, Esmail A, Usmani S, editors. PET/CT Imaging: Basics and Practice. Springer; 2022. ISBN: 978-3-030-75476-1
  • Vadi SK, Mittal BR. FDG PET/CT in Treatment Response Evaluation of Gynecological Malignancies. In: Fanti S et al., editors. Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology. Springer, Cham; 2021. p. 297–332. ISBN: 978-3-030-68857-8
  • Mittal BR, Singh H. Nuclear Medicine including PET. In: Kamath S et al. editors. API Text Book of Medicine (11th ed.). Delhi: CBS Publishers & Distributors Pvt. Ltd.; 2019. p. 2321–35
  • Mittal BR, Sunil HV, Agrawal K. Nuclear Imaging in Pulmonary Medicine. In: Jindal SK, editor. Text Book of Pulmonary and Critical Care Medicine (2nd ed.). Jaypee Brothers; 2017. p. 346–358
  • Sood A, Abhiram GA, Mittal BR. Role of Coronary Flow Reserve in Coronary Artery Disease. In: Mahapatra GN, Manoria PC, Jain D, editors. Cardiac Imaging Update. Jaypee Brothers; 2017. p. 100–105
  • Gorla AKR, Kohli H, Mittal BR. Nuclear Medicine Imaging in Nephrology. In: Jha PK, Kher V, editors. Manual of Nephrology. Jaypee Brothers; 2016. p. 95–110
  • Mittal BR, Parghane RV, Mohan Roop J. Application of PET and PET-CT in Cancer of the Gastrointestinal System. In: Das BK, editor. Positron Emission Tomography – A Guide for Clinicians. Springer; 2015. p. 113–122
  • Mittal BR, Mohan Roop J. Technical Considerations during PET Imaging. In: Das BK, editor. Positron Emission Tomography – A Guide for Clinicians. Springer; 2015. p. 33–36
  • Mittal BR. Nuclear Imaging. In: Munjal YP, editor. API Textbook of Medicine (10th ed.). Jaypee Brothers; 2015. p. 173–185
  • Mittal BR, Mohanroop J. Technical Considerations during PET Imaging. In: Das BK, Bal CS, Basu S, Mittal BR, Pradhan PK, editors. Positron Emission Tomography: A Guide for Clinicians. Srujan Publishers; 2014. p. 78–88
  • Mittal BR, Parghane R, Roopmohan J. Applications of PET in Cancers of Gastrointestinal System. In: Das BK, Bal CS, Basu S, Mittal BR, Pradhan PK, editors. Positron Emission Tomography: A Guide for Clinicians. Srujan Publishers; 2014. p. 239–259
  • Bhattacharya A, Mittal BR. Molecular Imaging. In: Gupta AK, Chowdhury V, Khandelwal N, editors. Diagnostic Radiology – Recent Advances and Applied Physics in Imaging (2nd ed.). Jaypee; 2013. p. 402–408
  • Mittal BR. Changing Strategy in the Management of CAD with Cardiac SPECT and PET Myocardial Perfusion Studies. In: Muruganathan A, editor. Medicine Update. The Association of Physicians of India; 2013. Vol. 23. p. 730–733
  • Mittal BR. Nuclear Imaging. In: Munjal YP, Sharma SK, Agarwal AK, et al., editors. API Text Book of Medicine (9th ed.). Jaypee Brothers; 2012. p. 100–112
  • Mittal BR. Nuclear Medicine in Pulmonary Imaging. In: Jindal SK, editor. Text Book of Pulmonary and Critical Care Medicine (1st ed.). Jaypee Brothers; 2011. p. 387–398
  • Mittal BR. Gastrointestinal Tract. In: Textbook of Nuclear Medicine by Indian College of Nuclear Medicine – Under Process
  • Das BK, Shukla AK, Kheruka S, Mittal BR. Experience in Image Quality Analysis in Nuclear Medicine. In: Rehani MM, editor. Diagnostic Imaging – Quality Assurance. Jaypee Brothers; 2010

Book an Appointment

arrow arrow